Phillips Benedict L, Ibrahim Maria, Greenhall George H B, Mumford Lisa, Dorling Anthony, Callaghan Chris J
Department of Nephrology and Transplantation, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Department of Inflammation Biology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Am J Transplant. 2021 Oct;21(10):3346-3355. doi: 10.1111/ajt.16574. Epub 2021 May 6.
Kidneys from donation after circulatory death (DCD) donors are utilized variably worldwide, in part due to high rates of delayed graft function (DGF) and putative associations with adverse longer-term outcomes. We aimed to determine whether the presence of DGF and its duration were associated with poor longer-term outcomes after kidney transplantation from DCD donors. Using the UK transplant registry, we identified 4714 kidney-only transplants from controlled DCD donors to adult recipients between 2006 and 2016; 2832 recipients (60·1%) had immediate graft function and 1882 (39·9%) had DGF. Of the 1847 recipients with DGF duration recorded, 926 (50·1%) had DGF < 7 days, 576 (31·2%) had DGF 7-14 days, and 345 (18·7%) had DGF >14 days. After risk adjustment, the presence of DGF was not associated with inferior long-term graft or patient survivals. However, DGF duration of >14 days was associated with an increased risk of death-censored graft failure (hazard ratio 1·7, p = ·001) and recipient death (hazard ratio 1·8, p < ·001) compared to grafts with immediate function. This study suggests that shorter periods of DGF have no adverse influence on graft or patient survival after DCD donor kidney transplantation and that DGF >14 days is a novel early biomarker for significantly worse longer-term outcomes.
来自心脏死亡后器官捐献(DCD)供体的肾脏在全球的利用情况各不相同,部分原因是移植肾功能延迟(DGF)发生率高以及与不良长期预后可能存在关联。我们旨在确定DGF的存在及其持续时间是否与DCD供体肾移植后的不良长期预后相关。利用英国移植登记处的数据,我们确定了2006年至2016年间从受控DCD供体到成年受者的4714例单纯肾移植;2832例受者(60.1%)移植后立即肾功能恢复,1882例(39.9%)发生DGF。在记录了DGF持续时间的1847例受者中,926例(50.1%)DGF<7天,576例(31.2%)DGF为7 - 14天,345例(18.7%)DGF>14天。经过风险调整后,DGF的存在与长期移植肾或患者生存率较低无关。然而,与移植后立即肾功能恢复的移植物相比,DGF持续时间>14天与死亡审查的移植肾失败风险增加(风险比1.7,p = 0.001)和受者死亡风险增加(风险比1.8,p<0.001)相关。这项研究表明,较短时间的DGF对DCD供体肾移植后的移植肾或患者生存没有不利影响,且DGF>14天是长期预后明显更差的一种新的早期生物标志物。